# Evaluating the Efficacy and Safety of Metformin in Vitiligo

> **NCT05607316** · PHASE2 · WITHDRAWN · sponsor: **University of Massachusetts, Worcester**

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** Metformin Hydrochloride

## Key facts

- **NCT ID:** NCT05607316
- **Lead sponsor:** University of Massachusetts, Worcester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-07
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-11-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to secure funding.
- **Last updated:** 2024-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05607316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05607316, "Evaluating the Efficacy and Safety of Metformin in Vitiligo". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05607316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*